Analyst desks are moving in opposite directions on consumer and property names this week.
ULTA got a boost from Deutsche Bank. Krisztina Katai upgraded the beauty retailer to Buy. Her target price rose to $695 from $692. Short interest sits at 5.4% of free float. The stock has a broad sell-side consensus skewed heavily toward Hold and Sell, so a Buy call stands out.
LULU faced the reverse. UBS analyst Jay Sole cut the athleticwear brand to Hold. His target fell to $120 from $124. Short sellers already have 9.7% of the free float on loan — among the higher readings in consumer discretionary.
ABT saw the most aggressive single-analyst move. TD Cowen's Joshua Jennings upgraded Abbott Laboratories to Buy. His target jumped to $135 from $115 — a $20 swing. With a $202 billion market cap and short interest below 1.5%, the bullish call faces little short-side friction.
Office REIT BXP received a notable target price increase from UBS. Michael Goldsmith lifted his target to $70 from $61. That is a 15% upward revision. Short interest at 6.6% of free float signals lingering skepticism toward office real estate. The gap between Goldsmith's optimism and broader bears makes this one to watch.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
